Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


08.07.2024

1 Am J Clin Pathol
1 Am J Hematol
5 Ann Hematol
7 Blood
1 Bone Marrow Transplant
1 Exp Hematol
2 Int J Hematol
1 J Natl Cancer Inst
6 Leuk Lymphoma
1 Leuk Res
10 Leukemia
1 Oncol Rep
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. FANG H, Wang SA, Beird HC, Tang Z, et al
    Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia.
    Am J Clin Pathol. 2024 Jun 30:aqae075. doi: 10.1093.
    PubMed         Abstract available


    Am J Hematol

  2. PEREZ CARRETERO C, Gonzalez T, Quijada Alamo M, Rigolin GM, et al
    Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.
    Am J Hematol. 2024 Jul 1. doi: 10.1002/ajh.27421.
    PubMed        


    Ann Hematol

  3. ZHENG J, Zhao Y, Luo Y, Yu J, et al
    Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysis.
    Ann Hematol. 2024 Jul 4. doi: 10.1007/s00277-024-05871.
    PubMed         Abstract available

  4. WANG J, Mu M, Zhu J, Yang J, et al
    Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria.
    Ann Hematol. 2024 Jul 3. doi: 10.1007/s00277-024-05866.
    PubMed         Abstract available

  5. CHEN R, Tao Q, Wu F, Zhai Z, et al
    DNT cells mediate resistance to CAR-T cells therapy in a pediatric patient with relapsed and refractory B-ALL.
    Ann Hematol. 2024;103:2551-2556.
    PubMed         Abstract available

  6. PANDA D, Tejwani N, Pandey P, Mehta A, et al
    Myeloid sarcoma with RAM phenotype in an adult male presenting with CNS relapse; no longer a pediatric disease.
    Ann Hematol. 2024;103:2561-2563.
    PubMed        

  7. CHEN Y, Chen Y, Wu Z, Li J, et al
    Nomogram predictive models for adult patients with acute lymphoblastic leukaemia based on real-world treatment outcomes.
    Ann Hematol. 2024;103:2393-2404.
    PubMed         Abstract available


    Blood

  8. ZHAO Y, Short NJ, Kantarjian HM, Chang TC, et al
    Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL.
    Blood. 2024;144:61-73.
    PubMed         Abstract available

  9. HASSAN N, Yi H, Malik B, Gaspard-Boulinc LC, et al
    Loss of stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML.
    Blood. 2024 Apr 5:blood.2024024072. doi: 10.1182/blood.2024024072.
    PubMed         Abstract available

  10. KROEZE E, Iaccarino I, Kleisman MM, Mondal M, et al
    Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
    Blood. 2024 Apr 8:blood.2024023938. doi: 10.1182/blood.2024023938.
    PubMed         Abstract available

  11. RADPOUR R, Simillion C, Wang B, Abbas HA, et al
    IL-9 Secreted by Leukemia Stem Cells Induces Th1-Skewed CD4+ T-Cells, which Promote Their Expansion.
    Blood. 2024 Jun 28:blood.2024024000. doi: 10.1182/blood.2024024000.
    PubMed         Abstract available

  12. QIAN Z, Yu F
    GADD45A: a key tumor suppressor in AML subtypes.
    Blood. 2024;144:6-7.
    PubMed        

  13. SRINAGESH HK, Jackson C, Shiraz P, Jeyakumar N, et al
    A Phase 1 Clinical Trial of NKTR-255 with CD19-22 CAR-T Cell Therapy for Refractory B-cell Acute Lymphoblastic Leukemia.
    Blood. 2024 Jul 5:blood.2024024952. doi: 10.1182/blood.2024024952.
    PubMed         Abstract available

  14. SUO S, Zhao D, Li F, Zhang Y, et al
    Homoharringtonine Inhibits the NOTCH/MYC Pathway and Exhibits Anti-Tumor Effects in T-Cell Acute Lymphoblastic Leukemia.
    Blood. 2024 Jul 5:blood.2023023400. doi: 10.1182/blood.2023023400.
    PubMed         Abstract available


    Bone Marrow Transplant

  15. BUG G, Labopin M, Kulagin A, Blaise D, et al
    Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT).
    Bone Marrow Transplant. 2024 Jul 3. doi: 10.1038/s41409-024-02331.
    PubMed         Abstract available


    Exp Hematol

  16. STRAUBE J, Janardhanan Y, Haldar R, Bywater MJ, et al
    Immune control in acute myeloid leukemia.
    Exp Hematol. 2024 Jun 12:104256. doi: 10.1016/j.exphem.2024.104256.
    PubMed         Abstract available


    Int J Hematol

  17. OYA S, Ozawa H, Morishige S, Maehiro Y, et al
    High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia.
    Int J Hematol. 2024 Jul 4. doi: 10.1007/s12185-024-03814.
    PubMed         Abstract available

  18. SAJIKI D, Yoshida N, Muramatsu H, Sakaguchi K, et al
    Clinical features of immature leukemias in children.
    Int J Hematol. 2024;120:117-127.
    PubMed         Abstract available


    J Natl Cancer Inst

  19. SCHAFER ES, Rushing T, Crews KR, Annesley C, et al
    Optimizing early phase clinical trial washout periods: a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
    J Natl Cancer Inst. 2024 Jul 4:djae165. doi: 10.1093.
    PubMed         Abstract available


    Leuk Lymphoma

  20. GOERGEN E, Al-Sawaf O
    The prognostic significance of genomic complexity in patients with CLL.
    Leuk Lymphoma. 2024;65:873-881.
    PubMed         Abstract available

  21. SURESH D, Rastogi P, Bal A, Lad D, et al
    Bridging the gap: understanding contemporary autopsies in acute leukemia by comparing ante-mortem and post-mortem profiles.
    Leuk Lymphoma. 2024 Jul 1:1-16. doi: 10.1080/10428194.2024.2372408.
    PubMed         Abstract available

  22. TAKIZAWA J, Teshima T, Ennishi D, Ichikawa S, et al
    Safety and efficacy of acalabrutinib and obinutuzumab in treatment-naive chronic lymphocytic leukemia: a Japanese phase 1 study.
    Leuk Lymphoma. 2024 Jul 1:1-9. doi: 10.1080/10428194.2024.2370436.
    PubMed         Abstract available

  23. ALHAJAHJEH A, Bewersdorf JP, Bystrom RP, Zeidan AM, et al
    Acute myeloid leukemia (AML) with chromosome 3 inversion: biology, management, and clinical outcome.
    Leuk Lymphoma. 2024 Jul 4:1-11. doi: 10.1080/10428194.2024.2367040.
    PubMed         Abstract available

  24. LAVIE G, Tadmor T
    It's time to change the standard of care for hairy cell leukemia?!
    Leuk Lymphoma. 2024 Jul 5:1-3. doi: 10.1080/10428194.2024.2371497.
    PubMed        

  25. TORELI ACM, Miranda-Galvis M, Sharara M, Addas-Carvalho M, et al
    Exploring SARS-CoV-2 infection and vaccine-induced immunity in chronic myeloid leukemia patients: insights from real-world data in Brazil and the United States.
    Leuk Lymphoma. 2024 Jul 5:1-10. doi: 10.1080/10428194.2024.2367057.
    PubMed         Abstract available


    Leuk Res

  26. XU Z, Zhang T, Hao J, Liu D, et al
    Identification of clonal relationship and prognostic significance in acute myeloid leukemia patients with concomitant increase in mast cells.
    Leuk Res. 2024;143:107539.
    PubMed        


    Leukemia

  27. ERNST P, Rinke J, Franke GN, Dicker F, et al
    Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation.
    Leukemia. 2024 Jul 4. doi: 10.1038/s41375-024-02327.
    PubMed        

  28. DIEDRICH JD, Dong Q, Ferguson DC, Bergeron BP, et al
    Correction: Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks.
    Leukemia. 2024 Jul 3. doi: 10.1038/s41375-024-02291.
    PubMed        

  29. YUN H, Zoller J, Zhou F, Rohde C, et al
    The landscape of RNA-chromatin interaction reveals small non-coding RNAs as essential mediators of leukemia maintenance.
    Leukemia. 2024 Jun 28. doi: 10.1038/s41375-024-02322.
    PubMed         Abstract available

  30. YAMAMOTO Y, Watanabe T, Ureshino H, Kurahashi Y, et al
    DNA demethylating agents for chemoprevention of oncovirus-associated leukemogenesis.
    Leukemia. 2024;38:1613-1616.
    PubMed        

  31. SHAO Y, Kay NE, Gale RP, Liang Y, et al
    Challenges in analyzing clinical trials testing Bruton tyrosine-kinase-inhibitora in chronic lymphocytic leukaemia.
    Leukemia. 2024;38:1469-1473.
    PubMed        

  32. SCOTT S, Devonshire A, Dillon R, Thiede C, et al
    Recommendations from the AML molecular MRD expert advisory board.
    Leukemia. 2024;38:1638-1641.
    PubMed        

  33. MASLAH N, Rety S, Bonnamy M, Aguinaga L, et al
    Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells.
    Leukemia. 2024;38:1630-1633.
    PubMed        

  34. GROSS G, Alkadieri S, Meir A, Itzhaki O, et al
    Improved CAR-T cell activity associated with increased mitochondrial function primed by galactose.
    Leukemia. 2024;38:1534-1540.
    PubMed         Abstract available

  35. SHIMONY S, Garcia JS, Keating J, Chen EC, et al
    Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients.
    Leukemia. 2024;38:1494-1500.
    PubMed         Abstract available

  36. KOVECSES O, Mercier FE, McKeague M
    Nucleic acid therapeutics as differentiation agents for myeloid leukemias.
    Leukemia. 2024;38:1441-1454.
    PubMed         Abstract available


    Oncol Rep

  37. MORINO Y, Sugiyama H, Yamane K, Kikuchi M, et al
    Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL?60 cells.
    Oncol Rep. 2024;52:109.
    PubMed         Abstract available


    PLoS One

  38. MOHAMMADIAN-HAFSHEJANI A, Farber IM, Kheiri S
    Global incidence and mortality of childhood leukemia and its relationship with the Human Development Index.
    PLoS One. 2024;19:e0304354.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.